Purpose: To assess the choroidal vascular changes using choroidal vascularity index (CVI) in patients with age-related macular degeneration (AMD) compared to controls. Methods: Enhanced depth imaging (EDI) optical coherence tomography (OCT) scans of 64 patients with unilateral or bilateral AMD were obtained. Images with a poorly demarcated choroidal-scleral interface (CSI) were excluded from the analysis. Foveal scans of 63 AMD eyes and 35 'normal fellow' eyes were analysed. Images of 30 eyes from 18 age-matched healthy subjects were included as controls. Choroidal vascularity index (CVI) was derived from binarization of EDI OCT images, using FIJI software. Results: The mean age was 56.50 AE 5.50 years for AMD patients and 52.25 AE 6.75 years for controls. All patients were treatment na€ ıve. Subfoveal choroidal thickness (SFCT) in AMD, 'normal fellow' eyes and controls was 314.02 AE 78.80 lm, 300.88 AE 53.85 lm and 278.5 AE 65.31 lm, respectively. Choroidal vascularity index (CVI) in AMD, 'normal fellow' eyes and controls was 64.04 AE 2.43%, 64.66 AE 2.25% and 66.07 AE 1.72%, respectively. Choroidal vascularity index (CVI) of both AMD and 'normal fellow' eyes was significantly lower compared to controls (p < 0.0001 and p = 0.007). The SFCT of AMD eye was not found to be significantly different from 'normal fellow eyes' (p = 0.45). Conclusion: There was no statistical difference in SFCT, but CVI was significantly lower in patients with AMD. Choroidal vascularity index (CVI) was also lower in 'normal fellow' AMD eyes as compared to controls. This suggests possible reduction in choroidal vascularity in eyes with AMD and also to a certain extent in the 'normal fellow' eyes without phenotypical manifestations and may suggest underlying choroidal morphological change leading to wet AMD.
Introduction
Age-related macular degeneration (AMD) is a leading cause of visual impairment worldwide, especially with ageing populations in many parts of the world (Lim et al. 2012) . Approximately 8.7% of the world population suffers from AMD. The projected number of people in 2020 with AMD is 196 million, increasing to 288 million in 2040 . Estimates indicate a substantial global burden of the disease in future.
The pathophysiology and risk factors for AMD are complex, and the symptoms manifest in multiple related but distinct forms (van Lookeren Campagne et al. 2014) . Disease manifestations may range from early dry AMD presenting with drusen and retinal pigment epithelium (RPE) abnormalities, to advanced AMD with geographic atrophy. 10-15% of cases are of the exudative type, with choroidal neovascularization (CNV) in neovascular AMD.
Subfoveal choroidal thickness (SFCT) variations on EDI OCT scans have been extensively studied in AMD. It has been reported that there is natural thinning of the choroid with age, with reports ranging from 16 lm to 54 lm of thinning per decade of life (Margolis & Spaide 2009; Ding et al. 2011; Tan et al. 2016b) . Within AMD itself, choroidal thickness may change in relation to disease manifestations. In the early disease process, choroidal thickness seems to be unaffected with regard to eyes with AMD (Wood et al. 2011) . In neovascular AMD, a thicker choroid was found compared to normal fellow eyes with non-neovascular AMD (Razavi et al. 2015) . However, Yiu et al. (2015) and Jonas et al. (2014) reported no change in choroidal thickness in different grades of AMD. Shin et al. (2015) investigated the relationship between choroidal thickness and treatment outcomes in wet AMD following intravitreal injection of antivascular endothelial growth factors, and found that patients with thin choroids had a higher prevalence of intra-/subretinal fluid and less visual gain 1 year after treatment.
Choroidal thickness appears to be a crude parameter to evaluate e597 abnormalities in choroidal vasculature. Furthermore, advancement in technology has provided further insight into both qualitative and quantitative measurements of choroidal vasculature and other volumetric data in choroidal pathology (Regatieri et al. 2012; Karampelas et al. 2013) . Evaluation of CVI in macular diseases has improved our understanding of the possible structural changes. As reported by our group previously, CVI was evaluated in a normal population (Agrawal et al. 2016a) , and found to be lower in exudative AMD (Wei et al. 2016) , decreased in eyes with diabetes mellitus (Tan et al. 2016a) , higher in patients with acute central serous chorioretinopathy (Agrawal et al. 2016b ). The monitoring of percentage change in CVI may be helpful in the monitoring of panuveitis (Agrawal et al. 2016c ). Being primarily a choroidal vascular disease, evaluation of choroidal vascularity may provide us with additional insight into choroidal angio-architectural changes in AMD. The same has been investigated in our recently published report on choroidal vascular changes in exudative AMD in Chinese cohort (Wei et al. 2016) .
In this report, we evaluated the SFCT and CVI in patients with both exudative and dry AMD in comparison with age-matched healthy controls in Indian eyes.
Materials and Methods
This was a retrospective cohort study of patients with AMD seen at a tertiary referral eye care centre in Southern India, from July 2013 to December 2015. Local ethics board approval was obtained to analyse the EDI OCT scans using public domain software (FIJI; http://imagej.nih.gov/ij, version 2.0.0-rc.15/1.49j, date: 2014-10-06) (Schindelin et al. 2012) . The research was conducted in accordance with the tenets set forth in the Declaration of Helsinki.
Eyes with treatment-na€ ıve AMD, both dry and wet, were included in the study. Eyes with scarred CNV; history of antivascular endothelial growth factor (anti-VEGF) therapy in any eye; and presence of any other retinal disease were excluded. Eyes were classified as 'normal fellow' eyes in the absence of characteristic features of AMD on fundus photography and/or OCT scans -such as drusen, CNV and retinal pigmentary changes.
Enhanced depth imaging (EDI) OCT scans of age-matched healthy controls were retrieved.
Collected data included demographic details, duration of symptoms if any and clinical findings. Highdefinition single EDI OCT scans across the central foveal region were obtained using the Cirrus Ò (Carl Zeiss Meditec, Dublin, CA, USA). A masked grader measured SFCT manually. The SFCT was defined as the vertical distance between the outer surface of the RPE and the CSI.
Binarization of EDI OCT images
A masked grader (NK) binarized the images to compute the CVI using the semi-automated method described previously by Sonoda et al. (2014) . and validated by our group (Agrawal et al. 2016a,b,c) . Details and supplementary information for the steps of image binarization is available in our previous publication (Agrawal et al. 2016a,b,c) . Briefly, EDI OCT scan passing through the central foveal/subfoveal region was selected and used for analysis. Binarization of the choroidal area in that scan was performed using the FIJI (IMAGEJ) software. The polygon tool was used to select the region of interest (ROI). Region of interest was plotted across the entire length of the EDI OCT scan to standardize the area of the ROI among all patients. The upper boundary of the ROI was traced along the choroid-RPE junction and the lower boundary along the CSI. Choroidal-scleral interface (CSI) was identified by looking at EDI OCT image, and based on the texture difference between choroial layer and sclera, the CSI was manually plotted using polygon tool. In cases with sub-RPE fluid, the upper segmentation line was traced below the border of sub-RPE fluid pocket using the manual polygon tool on IMAGEJ. Poor-quality EDI OCT scans with a poorly demarcated CSI due to non-differentiating textures and insufficient resolution were excluded from the analysis. Application of auto-threshold was performed after conversion to eight-bit images. Brightness was reduced to allow clear visualization of the choroidal vessels and minimize noise. Niblack's auto local threshold tool was then applied, to allow demarcation of the luminal or vascular area (LA) and the stromal or interstitial area (SA). The image was then converted back to an RGB (red, green, blue) image, and the luminal area was determined using the colour threshold tool. Across all three different thresholding steps (auto-threshold, Niblack's auto local threshold and colour threshold), we used the default standard settings in IMAGEJ plug in to allow us to standardize the thresholding values for all the scans for different patients.
Choroidal vascularity index (CVI) -defined as the proportion of luminal area to the total choroidal area -was then computed for all images (Agrawal et al. 2016a,b,c) . As the upper border of ROI was along the RPE, even choriocapillaris was selected in computation of CVI. However, with the current algorithm, the differentiation between choriocapillaris and Haller's and Sattler's layer was not possible. Choroidal vascularity index (CVI) hence represents a composite index of all the vascular structures within the choroid. A superimposed image of the binarized segment over the conventional EDI OCT scan represents the optically segmented choroid and its two components, that is vascular and stromal area (Fig. 1) .
Statistical analysis
Statistical analysis was performed using STATA (Statacorp 2013) . Continuous variables were expressed as mean AE standard deviation, and quantitative variables were expressed as frequency (%). After establishing the normality of the data, using two-tailed t-test, the dependant variables SFCT and CVI were compared between controls, 'normal fellow' eyes of patients with AMD and AMD eyes. Subgroup analysis was performed for AMD eyes with or without active CNV.
Results
A total of 128 eyes of 64 Indian patients with either unilateral (62 eyes) or bilateral (four eyes) AMD were recruited in our study. There were 30 female and 34 male, with a mean age of 56.50 AE 5.50 years. Thirty-six eyes of 18 participants (10 female and eight male) were recruited as controls. Mean age was 52.25 AE 6.75 years. There was no statistical difference in gender and age distribution between AMD patients and the controls (p = 0.37).
After excluding poor-quality scans, 63 eyes classified with AMD were segmented; 36 were dry AMD (with 16 patients having geographic atrophy), while 27 were wet AMD. All 27 eyes with wet AMD were treatment na€ ıve and had active CNV. Thirty-five eyes with apparently healthy 'normal fellow' eyes of AMD patients were included. Among the controls, six images were excluded due to poor quality, and 30 images were segmented and included for further analysis.
Subfoveal choroidal thickness (SFCT) for eyes with both dry and wet AMD was 314.02 AE 78.80 (range: 165-636) lm. Subfoveal choroidal thickness (SFCT) for 'normal fellow' eyes was 300.88 AE 53.85 (range: 188-409) lm. The SFCT for normal eyes 278.5 AE 65.31(range: 182-404) lm. The SFCT in both AMD patients and their 'normal fellow' eyes was higher compared to that in normal controls; however, this difference was not found to be statistically significant (p = 0.06 and 0.20 respectively). The SFCT of AMD eyes was not found to be significantly different from 'normal fellow eyes' (p = 0.45; Fig. 2 ). In the AMD subgroup analysis, SFCT of wet AMD group was 317.43 AE 76.83 lm (95% CI: 284.21-350.65), while SFCT of eyes in dry AMD group was 311.4 AE 81.48 lm (95% CI: 280.97-341.82). The difference in SFCT was not found to be statistically significant (p = 0.78; Fig. 3 ).
Choroidal vascularity index (CVI) of the AMD eyes (including both dry and wet) was 64.04 AE 2.43% (range: 57.10-69.97%). Choroidal vascularity index (CVI) of 'normal fellow' normal eyes was 64.66 AE 2.25% (range: 57.65-69.05%). Choroidal vascularity index (CVI) of normal controls was 66.07 AE 1.72% (range: 62.87-69.45%). Choroidal vascularity index (CVI) was found to be significantly lower for both AMD (p < 0.001) and the 'normal fellow' eyes (p = 0.007) compared to healthy control eyes. The CVI for AMD eyes was not found to be significantly different from the 'normal fellow' eyes (p = 0.21; Fig. 2 ). Choroidal vascularity index (CVI) of wet AMD group was 64.42 AE 2.51% (63.42-65.41), while CVI of dry AMD group was 63.75 AE 2. 37% (62.95-64.55 ). The difference in CVI was not found to be statistically significant (p = 0.29; Fig. 3 ).
Discussion
The advancement of technology has enabled the segmentation of the choroid allowing us to study the choroidal structural changes. It enables us to evaluate the various layers and its vascular components. Fully automated segmentation software has not yet been developed to measure the CVI, although other algorithms have been developed for the measurement of choroidal thickness (Mahajan et al. 2013; Beaton et al. 2015; Gupta et al. 2015; Zhang et al. 2015) . The validity, usefulness and applicability of segmentation of the choroid in a clinical setting have yet to be firmly established.
In the present report, we did not find any statistical significant difference in SFCT between normal and AMD eyes. This concurs with findings reported by Jonas et al. (2014) . Jonas et al. did not found any significant thinning or thickening of the choroid in patients with either exudative or non-exudative AMD. Margolis & Spaide (2009) demonstrated the significant interindividual differences in SFCT in patients with increasing age and varying degrees of refractive errors. Based on these previously published reports, we investigated the novel tool of CVI to assess the differences between normal and AMD eyes.
Choroidal vascularity index (CVI) was calculated by finding the proportion of the choroidal vascular luminal area to the total choroidal area (Agrawal et al. 2016a,b,c) . In our unpublished data, we have investigated the influence of scanning area on CVI measurements and we have found no statistically significant difference in CVI using subfoveal, central and total macular scans. The most significant finding in our study was that CVI was significantly lower in patients with AMD compared to normal controls. This implies that the volume of choroidal vasculature on a two-dimensional scan was lower in AMD patients compared to normal controls. We also found a significantly lower CVI even for the 'normal fellow' eyes of AMD patients compared to normal eyes, which were otherwise clinically normal in appearance. This may suggest that subclinical disease may be present, as the choroidal ischaemia may precede phenotypical manifestations of AMD. The reduction in CVI would suggest either secondary effect of AMD or role of underlying choroidal ischaemia in the pathogenesis of AMD (Wei et al. 2016) . The cause-effect relationship could not be ascertained from this in vivo imaging study. This then potentially leads to neovascularization and the development of CNV in wet AMD. This is supported by other studies as well, with the usage of various methods to evaluate choroidal blood vascularity (Wei et al. 2016) . Using fluorescein and indocyanine green angiography, a prolonged choroidal filling phase has been interpreted to indicate reduced choroidal perfusion (Giovannini et al. 1994; Pauleikhoff et al. 1999) . Laser Doppler flowmetry has long been used to evaluate choroidal blood flow in the macula in terms of velocity, volume and flow. By this method, it has been demonstrated that choroidal blood flow and volume is reduced in AMD (Grunwald et al. 1998 ) and associated with an increased risk for CNV (Grunwald et al. 2005) . Longitudinal studies have further linked the lower choroidal perfusion as a risk factor for the development of CNV (Metelitsina et al. 2008; Boltz et al. 2010) . Similar findings have been found using other methods such as pulsatile ocular blood flow (Mori et al. 2001) and B scan radiofrequency ultrasound (Coleman et al. 2013) .
Morphometric analysis of Bruch's membrane, the choriocapillaris and the choroid was performed by Ramrattan et al. (1994) , which found age correlated to reduction in choriocapillary density. In advanced stages of AMD, there was a significant decrease in choriocapillary density and diameter compared to normal maculae, although choroidal thickness remained the same. This corroborates with our findings using our segmentation techniques. Likewise, McLeod et al. (2002 McLeod et al. ( , 2009 ) performed histopathological studies in post-mortem eyes and have reported loss of choriocapillaris in geographic atrophy as well as adjacent to CNV in wet AMD.
Hence, CVI may be a helpful tool in the evaluation of patients with and at high risk for AMD. Optical coherence tomography (OCT) is now an increasingly ubiquitous method of analysis of the macula by a vast majority of clinicians in routine practice and hence readily available. Enhanced depth imaging (EDI) OCT has also been found to have good intra-observer reproducibility and interobserver reproducibility (Shao et al. 2013 ). In comparison with other means of measuring choroidal vascularity, the calculation of CVI is relatively more accessible to clinician by using EDI OCT imaging with subsequent segmentation. Although there currently is no automated software for the calculation of CVI, the process is relatively simple and automated software may be readily developed should it prove sufficient utility.
There are several limitations in our study. Our sample size was relatively small. Choroidal vascularity index (CVI) is not the actual measure of the blood flow velocity, as it does not provide any information about dynamic flow. In addition, medical history of the patients was not obtained in detail, and each group may have a varying amount of patients with underlying ischaemic risk factors, which may or may not affect CVI; however, we have not assessed the same in this study. Dry AMD patients could not be stratified into those with advance disease with geographic atrophy or with milder disease due to limited number of eyes in this study cohort; it would be worth exploring the trends in CVI with respect to disease progression in patients with dry AMD.
In conclusion, choroidal vascularity appears to be decreased in eyes with AMD as well normal fellow eyes of AMD subjects in comparison with agematched healthy subjects. Choroidal vascularity index (CVI) may be a helpful tool in the workup and evaluation of a patient with AMD. Future studies correlating structural and functional change in choroidal vasculature may provide further improvement in pathophysiology of AMD and the wide spectrum of manifestations.
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